JUSTIN CASEY: Open Payments
NPI 1053549063 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 67 payments from 20 companies in 2025. Trend: 2023 $1,837 · 2024 $1,846 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $200 |
| Novo Nordisk Inc | 12 | $168 |
| Abbott Laboratories | 8 | $150 |
| Amgen Inc. | 11 | $141 |
| PFIZER INC. | 5 | $87 |
| Averitas Pharma Inc. | 3 | $71 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $35 |
| Medtronic, Inc. | 1 | $34 |
Products named: FREESTYLE LIBRE 3, FARXIGA, REPATHA, AIRSUPRA, QUTENZA, NURTEC ODT, Wegovy, INJECTAFER.
Industry payments across AL — which companies pay providers there.
